Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2000-02-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/S0091-3057(99)00170-7PMID 10672974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models

  2005cited by this paper
• Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its congeners

  2005cited by this paper
• Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor

  1999cited by this paper
• Memory deficits associated with recreational use of “ecstasy” (MDMA)

  1999cited by this paper
• The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.

  1998cited by this paper
• MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.

  1998cited by this paper
• An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

  1998cited by this paper
• Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

  1998cited by this paper
• Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

  1998cited by this paper
• The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

  1998cited by this paper
• Analysis of the 5‐HT1A receptor involvement in passive avoidance in the rat

  1998cited by this paper
• Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits

  1998cited by this paper
• Memory impairment in abstinent MDMA ("Ecstasy") users

  1998cited by this paper
• Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats.

  1997cited by this paper
• Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids

  1997cited by this paper
• Serotonin receptors in cognitive behaviors.

  1997cited by this paper
• Pathology of deaths associated with "ecstasy" and "eve" misuse.

  1996cited by this paper
• Excessive serotonin release, not depletion, leads to memory impairments in rats.

  1996influential reference
• Contents of "ecstasy".

  1995cited by this paper
• Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.

  1995cited by this paper
• Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)

  1995cited by this paper
• The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.

  1995cited by this paper
• Immunocytochemical evidence for serotonergic neurotoxicity of N-ethyl-methylenedioxyamphetamine (MDE).

  1994cited by this paper
• 3,4-Methylenedioxymethamphetamine, serotonin and memory.

  1993cited by this paper
• Hyperthermia associated with 3,4‐methylenedioxyethamphetamine (‘Eve’)

  1993cited by this paper
• Physiopharmacological interactions between stress hormones and central serotonergic systems.

  1993cited by this paper
• 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task.

  1992cited by this paper
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

  1992influential reference
• The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

  1992cited by this paper
• Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset.

  1991cited by this paper
• Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-methylenedioxyamphetamine discriminative stimulus.

  1991cited by this paper
• Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.

  1991cited by this paper
• Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

  1990cited by this paper
• Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.

  1990cited by this paper
• Characterization of [3H]Paroxetine Binding in Rat Brain

  1988cited by this paper
• Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

  1988cited by this paper
• Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs.

  1987influential reference
• 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain.

  1987cited by this paper
• A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.

  1987influential reference
• Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT

  1983cited by this paper

• Novel Ways of Targeting the Dopamine Transporter.

  2025cites this paper
• MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy.

  2023cites this paper
• Cerebrospinal Fluid Serotonin level as Biomarker for Neurotoxicity after 3,4-Methylenedioxymethamphetamine (MDMA)

  2022cites this paper
• Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy

  2020cites this paper
• Title Cognitive Effects of MDMA in Laboratory Animals : A Systematic Review Focusing on Dose Permalink

  2019influential citation
• Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose

  2019cites this paper
• Acute MDMA and Nicotine Co-administration: Behavioral Effects and Oxidative Stress Processes in Mice

  2018cites this paper
• Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents

  2017cites this paper
• Dopamine Receptors Gene Expression in Male Rat Hippocampus after Administration of MDMA (Ecstasy)

  2015cites this paper
• Acute Effects of Ecstasy on Memory Are more Extensive than Chronic Effects

  2014cites this paper
• Acute and Chronic Effects of 3-4,Methylenedioxymethamphetamine on Pyramidal Cells of Hippocampus

  2014cites this paper
• Effect of serotonin-modulated anticonsolidation protein on formation of long-term memory in the learning model of active avoidance in the carp (Cyprinus carpio)

  2014cites this paper
• Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats.

  2014cites this paper
• Studies of the Role of Serotonin-Modulating Anticonsolidation Protein in Memory Formation in Rats in a Shuttle Box

  2013cites this paper
• [The role of serotonin-modulated anticonsolidation protein in memory formation in rats in a shuttle box].

  2012cites this paper
• Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: Correlations between behavior and neurochemistry

  2012cites this paper
• Efectos conductuales y neuroquímicos del consumo de éxtasis y cocaína en ratones adolescentes.

  2009cites this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cites this paper
• Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice.

  2009cites this paper
• Phosphodiesterase 5 inhibitors prevent 3,4‐methylenedioxymethamphetamine‐induced 5‐HT deficits in the rat

  2009cites this paper
• Neurotoxic Thioether Adducts of 3,4-Methylenedioxymethamphetamine Identified in Human Urine After Ecstasy Ingestion

  2009cites this paper
• Neuronal cell adhesion molecule deletion induces a cognitive and behavioral phenotype reflective of impulsivity

  2008cites this paper
• On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.

  2008cites this paper
• The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).

  2006cites this paper
• Party Drugs: Properties, Prevalence, Patterns, and Problems

  2005cites this paper
• Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.

  2005cites this paper
• 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system.

  2005cites this paper
• Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats

  2005cites this paper
• Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.

  2004cites this paper
• NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment

  2004influential citation
• Memory reactivation in rats treated with the 5-HT1A agonist 8-OH-DPAT: a case of gone, but not forgotten.

  2004cites this paper
• Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats.

  2003cites this paper
• 3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats.

  2002cites this paper
• Impulsivity and Substance Abuse: What Is the Connection?

  2002cites this paper
• Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.

  2001cites this paper